...
首页> 外文期刊>Journal of clinical gastroenterology >Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites. The role of postparacentesis plasma volume expansion.
【24h】

Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites. The role of postparacentesis plasma volume expansion.

机译:大容量穿刺术治疗肝硬化顽固性腹水患者。穿刺后血浆体积扩张的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Ascites is a common complication of cirrhosis and has a major clinical impact on the patient's general well-being. Approximately 10% of patients with cirrhosis can develop diuretic-resistant, tense ascites that requires other therapeutic interventions. In recent years, there has been a renewed interest in large-volume paracentesis (LVP) as a safe, simple, and inexpensive method to substitute for other more complicated and costly therapeutic interventions for refractory ascites. In this article, we review the latest literature supporting the use of LVP for the treatment of refractory, tense ascites. We also address the role of intravascular volume expansion after LVP, note that usually no postparacentesis volume expansion is necessary, and compare, when used, the different plasma volume expanders in terms of efficacy, safety, and cost.
机译:腹水是肝硬化的常见并发症,对患者的总体健康状况具有重大的临床影响。大约10%的肝硬化患者会发展出对利尿药的紧张性腹水,需要采取其他治疗措施。近年来,人们越来越关注大体积穿刺术(LVP),它是一种安全,简单,廉价的方法,可以替代其他更复杂,成本更高的顽固性腹水治疗干预措施。在本文中,我们回顾了支持LVP用于治疗难治性腹水的最新文献。我们还讨论了LVP后血管内体积扩张的作用,请注意通常不需要穿刺后体积扩张,并在使用时比较不同血浆体积扩张剂的功效,安全性和成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号